拷贝数变异与前列腺癌转移致死性进展相关
研究基于两个前列腺癌根治术队列(FH 队列 n=323,EV 队列 n=78)的原发肿瘤组织,利用 Illumina HM450K 甲基化芯片数据推断拷贝数变异(CNA)。在 FH 队列发现 15 个复发性 CNA 与转移相关并在 EV 队列重复验证(p<0.05),其中 11 个在校正 Gleason 评分后仍与转移进展相关。
要点
- CNA 可从 HM450K DNA 甲基化数据中可靠检出。
- 11 个复发性 CNA 与根治术后转移致死事件相关,且在校正 Gleason 评分后仍显著。
- 这些 CNA 可在 Gleason 评分之外改善对转移进展的预测。
核心结论
- 原发前列腺肿瘤中检测到的复发性拷贝数变异与根治性前列腺切除术后转移致死性进展相关,并可在 Gleason 评分之外改善预测。
研究设计与样本
- 对两个临床局限期前列腺癌根治术队列的原发肿瘤组织行表观基因组全 DNA 甲基化谱分析:Fred Hutchinson 癌症研究中心队列 n=323,Eastern Virginia 医学院队列 n=78,前瞻随访至少 5 年。
- CNA 使用 R 包 ChAMP 识别;转移经骨扫描、MRI、CT 或活检阳性确认,死因经死亡证明确认。
主要发现
- 在 FH 队列检出 15 个复发性 CNA 与转移相关,并在 EV 队列重复验证(p<0.05,模型未校正 Gleason 评分)。
- 校正 Gleason 评分后,11 个复发性 CNA 在 FH 队列与转移进展相关并在 EV 队列验证(p<0.05)。
临床怎么用
- 对于根治术后临床局限期前列腺癌患者,可考虑基于甲基化芯片推断的 CNA 辅助识别转移高危者,弥补 Gleason 评分不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: Aside from Gleason score few factors accurately identify the subset of prostate cancer (PCa) patients at high risk for metastatic progression. We hypothesized that copy number alterations (CNAs), assessed using CpG methylation probes on Illumina Infinium® Human Methylation450 (HM450K) BeadChip arrays, could identify primary prostate tumors with potential to develop metastatic progression. METHODS: Epigenome-wide DNA methylation profiling was performed in surgically resected primary tumor tissues from two cohorts of PCa patients with clinically localized disease who underwent radical prostatectomy (RP) as primary therapy and were followed prospectively for at least 5 years: (1) a Fred Hutchinson (FH) Cancer Research Center-based cohort (n = 323 patients); and (2) an Eastern Virginia (EV) Medical School-based cohort (n = 78 patients). CNAs were identified using the R package ChAMP. Metastasis was confirmed by positive bone scan, MRI, CT or biopsy, and death certificates confirmed cause of death. RESULTS: We detected 15 recurrent CNAs were associated with metastasis in the FH cohort and replicated in the EV cohort (p < 0.05) without adjusting for Gleason score in the model. Eleven of the recurrent CNAs were associated with metastatic progression in the FH cohort and validated in the EV cohort (p < 0.05) when adjusting for Gleason score. CONCLUSIONS: This study shows that CNAs can be reliably detected from HM450K-based DNA methylation data. There are 11 recurrent CNAs showing association with metastatic-lethal events following RP and improving prediction over Gleason score. Genes affected by these CNAs may functionally relate to tumor aggressiveness and metastatic progression.
引用
- Wang X, Grasso CS, Jordahl KM, et al. Copy number alterations are associated with metastatic-lethal progression in prostate cancer. Prostate Cancer Prostatic Dis. 2020. PMID: 32071439. doi:10.1038/s41391-020-0212-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。